{
    "success": true,
    "data": {
        "leverage": true,
        "derivates": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthethic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Leverage",
            "Swaps",
            "Complex Index",
            "Daily Compounding Risk"
        ],
        "classification": "complex",
        "supporting_data": "The asset is classified as complex based on several overriding factors derived from the provided MiFID II framework and ESMA guidelines. Firstly, the product explicitly uses 3x daily leverage, which introduces a complex compounding effect and path dependency risk that is difficult for a typical retail investor to understand. The recommended holding period of only one day is a direct consequence of this complexity. Secondly, the ETP achieves its objective through synthetic replication using a swap with a counterparty (Natixis), which is a derivative instrument central to the strategy. This introduces counterparty and collateral risks. According to the rules, using derivatives as an integral part of the investment objective, rather than for efficient portfolio management, is a key indicator of complexity. The product is an ETP and not a UCITS, meaning the baseline presumption of non-complexity does not apply. Finally, the Key Information Document itself contains a mandatory comprehension alert stating, 'You are about to purchase a product that is not simple and may be difficult to understand,' which is a requirement for products deemed complex under PRIIPs and MiFID II.",
        "final_assessment": "Complex"
    }
}